The Arts Residences Achieves 60 Percent Sales Milestone San

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
20
The Arts Residences Achieves 60 Percent Sales Milestone

San Antonio, Texas, May 17, 2018 (GLOBE NEWSWIRE) -- DC Partners announced it has achieved a major milestone, selling 60 percent of the condominium homes in The Arts Residences at the Thompson San Antonio hotel since its sales office opened last May. 

“We are proud of reaching 60 percent sold in a year! The interest in this property is increasing daily, and we are continuing to see a large influx of buyers from the San Antonio area,” said Roberto Contreras, CEO of DC Partners, which is developing its first project in the San Antonio market. “Homebuyers are recognizing the unique nature and timeless value of The Arts Residences, and San Antonio will benefit enormously from this project, which creates jobs and boosts the local economy.” 

Most of the residential condominiums sold in The Arts Residences thus far have been purchased by longtime San Antonio residents from the city’s upscale neighborhoods who are transitioning to a centrally located, highly secure, genteel lifestyle. Living at The Arts Residences will put them at the epicenter of San Antonio’s performing arts, dining and shopping district. It is the first downtown high-rise luxury development to offer the location and range of services these discerning buyers have long sought. 

In its March 2018 issue,  Money Magazine  named The Thompson Hotels the “Best Luxury Hotels” in the United States, after analyzing 31 hotel brands rated four or more stars and with an average nightly room price of $300-plus. “If you’re going to pay high prices, make sure you’re getting a hotel that has a track record of excellence,” the article said. The boutique hotel chain has 10 hotels and resorts across four states and is building out quickly, with seven more hotels under development, including the Thompson San Antonio. 

“This will soon be the most coveted residential address in San Antonio,” said Karla Dupre, director of sales for Kuper Sotheby International Realty, which exclusively handles sales for The Arts Residences at the Thompson San Antonio hotel. “Seven of these incomparable, über-luxurious condominium homes sold within the past few weeks. We still have a great unit mix with incredible views available, we encourage interested parties to visit the sales office sooner, rather than later.”

Owners will enjoy round-the-clock security and an array of onsite amenities, including a restaurant with a world-class chef; a 5,000 square-foot pool deck with cabanas and pool bar; a lavish, relaxing spa; a state-of-the-art fitness center; and 24-hour room service and concierge service. The for-sale residences are priced from the high $400s to over $4.5 million for penthouses. The general contractor for the project is San Antonio-based Jordan Foster Construction. 

The Arts Residences at the Thompson San Antonio Hotel is slated for completion in the first quarter of 2020. For more information please visit  http://theartsresidences.com or contact our sales gallery to schedule your tour at (210) 227-4840.   

 

###

 

About The Art Residences at the Thompson  San Antonio 

The Arts Residences at the Thompson San Antonio hotel is San Antonio’s premier River Walk address, with luxurious surroundings, refined details, private entrance, concierge service for residents and 24-hour security. Located in the epicenter of San Antonio’s vibrant performing arts district, the 337,000-plus-square-foot mixed-use development encompasses The Arts Residences’ luxury-living condominiums atop San Antonio’s first Thompson Hotel and a restaurant with a world-class chef. Developed by DC Partners and San Antonio-based Universal Service Group, and designed by Powers Brown Architecture, the project is scheduled to be completed in first quarter 2020. The Arts Residences at the Thompson Hotel is exclusively marketed by Kuper Sotheby’s International Realty. For more information, visit  http://theartsresidences.com . 

About DC Partners

DC Partners is a real estate development and investment firm with the financial strength and expertise to complete projects of all sizes and asset types, including high-quality high-rise, mid-rise, mixed-use and suburban projects. The company uses a broad range of investment strategies to pursue acquisition and development opportunities through the EB5 program, as well as traditional development approaches. Well-known for its landmark projects, DC Partners’ portfolio consists of more than 1.5 million square feet, with properties including office facilities, mixed-use centers, hospitality, multi-family, residential communities and luxury high-rise condominiums. Among its most recent luxury condominium projects are the Cosmopolitan, Astoria, Arabella, Marlowe, Chateau Ten and the Arts Residences at the Thompson San Antonio. For more information, visit  http://www.dcpartners.com . 

 

 

Attachments

Lesley Hile Ford The Arts Residences at the Thompson San Antonio 5123635160 lesley@theprboutique.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 125

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
PexarBolt's CES Honor Meets a Real Crowdfunding Test

Updated Category News Views 77

A little touchscreen bolted onto a dock would usually make me roll my eyes. This time, Pexar has at least put enough muscle behind the gimmick to deserve a harder look. The PexarBolt Ultra TBT5 Dock was named a CES Innovation Awards 2027 Honoree in Computer Peripherals & Accessories, following an IFA 2026 Innovation Awards honor only two months after its launch. Awards do...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Six LIFE Photographers Bring History Into Florida Focus

Updated Category News Views 72

Seventy photographs can make a pretty loud argument when the historical record has been this lopsided. The Ashley Gibson Barnett Museum of Art at Florida Southern College has brought LIFE: Six Women Photographers to Lakeland, and it deserves more than the usual polite nod given to a traveling museum show. Open since November 14, 2026, and running through March 7, 2027,...

Continue Reading
Simmons Clarifies Texas Loan Exposure, But Risks Remain

Updated Category News Views 87

A $45 million discrepancy is not a rounding error, and Simmons First National has every reason to swat it down hard. The bank says recent reporting overstated financing tied to a Texas multifamily development at $133 million. Its stated total is roughly $88 million, with about $44 million participated to another financial institution. For shareholders in NASDAQ:SFNC, that...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 32

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 100

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 40

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Significant Unusual Options Activity Signals Opportunity in GOOGL

Updated Category News Views 97

Analyzing Recent Options Activity for Alphabet Currently, investors are exhibiting a strong bullish sentiment towards Alphabet (NASDAQ: GOOGL), a trend that is capturing the attention of market participants. Recent observations of public options have revealed significant movements in GOOGL, hinting at potential changes ahead. Recent analyses have uncovered 129 unusual...

Continue Reading
Encore and UKG Introduce Innovative Overtime Savings Program

Updated Category News Views 298

Encore and UKG Join Forces for Employee Financial Wellness Encore, a prominent global leader in event technology and production services, has unveiled an innovative ‘Overtime Savings Program’ in collaboration with UKG, a top provider of HR and workforce management solutions. This remarkable initiative aims to empower Encore's frontline workers, allowing them to save...

Continue Reading
Discover Incredible Returns from Texas Pacific Land Investments

Updated Category News Views 160

The Incredible Growth of Texas Pacific Land Corp Texas Pacific Land Corp (NYSE: TPL) has marked its presence in the market with an outstanding performance over the past 15 years. The company has outshone the market median by an impressive 32.71% annually, which translates to a staggering average annual return of 45.46%. With a current market capitalization nearing $20.51...

Continue Reading
Cypherpunk Q2 2026: Zcash Growth Sparks Market Buzz

Updated Category News Views 76

Cypherpunk Technologies' Stellar Q2 Performance Sit tight, folks, because Cypherpunk Technologies just unleashed a financial update that's got the market buzzing. They've reported a staggering net income of $39.4 million for Q2 2026, quite the turnaround from a $16.6 million loss in the same quarter last year. It's a serious win, no doubt pumped up by their fruitful Zcash...

Continue Reading
Exciting Findings from Aicuris’ Clinical Trials of AIC468

Updated Category News Views 182

Encouraging Insights into AIC468 from Clinical Trials Recently, a notable advancement in medical research has emerged from Aicuris Anti-infective Cures AG regarding its novel treatment, AIC468. This drug is an innovative antisense oligonucleotide targeting the BK virus, particularly in kidney transplant recipients. The first-in-human (FIH) Phase 1 trial has provided...

Continue Reading